Akshay Jain

1.3k total citations
21 papers, 993 citations indexed

About

Akshay Jain is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Akshay Jain has authored 21 papers receiving a total of 993 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Epidemiology. Recurrent topics in Akshay Jain's work include RNA Interference and Gene Delivery (9 papers), Advanced biosensing and bioanalysis techniques (6 papers) and Liver physiology and pathology (4 papers). Akshay Jain is often cited by papers focused on RNA Interference and Gene Delivery (9 papers), Advanced biosensing and bioanalysis techniques (6 papers) and Liver physiology and pathology (4 papers). Akshay Jain collaborates with scholars based in United States and Austria. Akshay Jain's co-authors include Kun Cheng, Zhen Zhao, Ashutosh Barve, Yuanke Li, Wei Jin, Zhijin Chen, John Fetse, Hao Liu, Hao Liu and Ravi Shukla and has published in prestigious journals such as The Journal of Immunology, ACS Applied Materials & Interfaces and Journal of Controlled Release.

In The Last Decade

Akshay Jain

21 papers receiving 986 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Akshay Jain United States	16	503	271	270	152	143	21	993
Zhen Zhao China	19	502 1.0×	239 0.9×	206 0.8×	154 1.0×	135 0.9×	38	1.0k
Tracie Delgado United States	8	660 1.3×	235 0.9×	333 1.2×	278 1.8×	233 1.6×	11	1.5k
Scott Barros United States	14	1.8k 3.7×	321 1.2×	372 1.4×	188 1.2×	291 2.0×	20	2.4k
Timofei S. Zatsepin Russia	25	1.8k 3.6×	255 0.9×	156 0.6×	155 1.0×	109 0.8×	167	2.4k
Jinzi J. Wu United States	16	777 1.5×	96 0.4×	123 0.5×	175 1.2×	60 0.4×	41	1.2k
Shan Guan China	19	796 1.6×	134 0.5×	137 0.5×	149 1.0×	156 1.1×	51	1.2k
Weiwei Mu China	19	360 0.7×	616 2.3×	329 1.2×	205 1.3×	284 2.0×	49	1.2k
Troy O. Harasym Canada	21	1.3k 2.7×	483 1.8×	915 3.4×	306 2.0×	174 1.2×	45	2.2k
Chang G. Peng United States	10	1.7k 3.3×	259 1.0×	134 0.5×	55 0.4×	97 0.7×	13	2.0k

Countries citing papers authored by Akshay Jain

Since Specialization

Citations

This map shows the geographic impact of Akshay Jain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akshay Jain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akshay Jain more than expected).

Fields of papers citing papers by Akshay Jain

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akshay Jain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akshay Jain. The network helps show where Akshay Jain may publish in the future.

Co-authorship network of co-authors of Akshay Jain

This figure shows the co-authorship network connecting the top 25 collaborators of Akshay Jain. A scholar is included among the top collaborators of Akshay Jain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akshay Jain. Akshay Jain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jain, Akshay, Gang Hu, Qi Zheng, et al.. (2023). Impact of the TLR4 agonist BECC438 on a novel vaccine formulation against Shigella spp.. Frontiers in Immunology. 14. 1194912–1194912. 4 indexed citations

Liu, Hao, Yanli Liu, Zhen Zhao, et al.. (2022). Discovery of Anti-PD-L1 Human Domain Antibodies for Cancer Immunotherapy. Frontiers in Immunology. 13. 838966–838966. 10 indexed citations

Patel, Pratikkumar, John Fetse, Chien‐Yu Lin, et al.. (2022). Development of amino acid-modified biodegradable lipid nanoparticles for siRNA delivery. Acta Biomaterialia. 154. 374–384. 26 indexed citations

Harberts, Erin, Sarah Valencia, Chelsea Sanders, et al.. (2020). Optimization of RG1-VLP vaccine performance in mice with novel TLR4 agonists. Vaccine. 39(2). 292–302. 20 indexed citations

Jain, Akshay, Gang Hu, David K. Johnson, et al.. (2020). Preformulation Characterization and the Effect of Ionic Excipients on the Stability of a Novel DB Fusion Protein. Journal of Pharmaceutical Sciences. 110(1). 108–123. 3 indexed citations

Zhao, Zhen, Yuanke Li, Hao Liu, et al.. (2020). Co-delivery of IKBKE siRNA and cabazitaxel by hybrid nanocomplex inhibits invasiveness and growth of triple-negative breast cancer. Science Advances. 6(29). eabb0616–eabb0616. 63 indexed citations

Barve, Ashutosh, Akshay Jain, Hao Liu, Zhen Zhao, & Kun Cheng. (2020). Enzyme-responsive polymeric micelles of cabazitaxel for prostate cancer targeted therapy. Acta Biomaterialia. 113. 501–511. 92 indexed citations

Boeszoermenyi, Andras, Barbara Ogórek, Akshay Jain, Haribabu Arthanari, & Gerhard Wagner. (2020). The precious fluorine on the ring: fluorine NMR for biological systems. Journal of Biomolecular NMR. 74(8-9). 365–379. 41 indexed citations

Chen, Zhijin, Akshay Jain, Hao Liu, Zhen Zhao, & Kun Cheng. (2019). Targeted Drug Delivery to Hepatic Stellate Cells for the Treatment of Liver Fibrosis. Journal of Pharmacology and Experimental Therapeutics. 370(3). 695–702. 77 indexed citations

10.

Zhao, Zhen, Yuanke Li, Ravi Shukla, et al.. (2019). Development of a Biocompatible Copolymer Nanocomplex to Deliver VEGF siRNA for Triple Negative Breast Cancer. Theranostics. 9(15). 4508–4524. 43 indexed citations

11.

Li, Yuanke, Zhen Zhao, Hao Liu, et al.. (2019). Development of a Tumor-Responsive Nanopolyplex Targeting Pancreatic Cancer Cells and Stroma. ACS Applied Materials & Interfaces. 11(49). 45390–45403. 40 indexed citations

12.

Liu, Hao, Zhen Zhao, Li Zhang, et al.. (2019). Discovery of low-molecular weight anti-PD-L1 peptides for cancer immunotherapy. Journal for ImmunoTherapy of Cancer. 7(1). 270–270. 104 indexed citations

13.

Jain, Akshay, Ashutosh Barve, Zhen Zhao, et al.. (2019). Targeted Delivery of an siRNA/PNA Hybrid Nanocomplex Reverses Carbon Tetrachloride‐Induced Liver Fibrosis. Advanced Therapeutics. 2(8). 27 indexed citations

14.

Jin, Wei, Akshay Jain, Hao Liu, Zhen Zhao, & Kun Cheng. (2018). Noncovalent Attachment of Chemical Moieties to siRNAs Using Peptide Nucleic Acid as a Complementary Linker. ACS Applied Bio Materials. 1(3). 643–651. 5 indexed citations

15.

Chen, Zhijin, Hao Liu, Akshay Jain, et al.. (2017). Discovery of Aptamer Ligands for Hepatic Stellate Cells Using SELEX. Theranostics. 7(12). 2982–2995. 42 indexed citations

16.

Zhao, Zhen, Yuanke Li, Akshay Jain, et al.. (2017). Development of a peptide-modified siRNA nanocomplex for hepatic stellate cells. Nanomedicine Nanotechnology Biology and Medicine. 14(1). 51–61. 44 indexed citations

17.

Shukla, Ravi, Akshay Jain, Zhen Zhao, & Kun Cheng. (2016). Intracellular trafficking and exocytosis of a multi-component siRNA nanocomplex. Nanomedicine Nanotechnology Biology and Medicine. 12(5). 1323–1334. 48 indexed citations

18.

Barve, Ashutosh, Akshay Jain, Hao Liu, Wei Jin, & Kun Cheng. (2016). An enzyme-responsive conjugate improves the delivery of a PI3K inhibitor to prostate cancer. Nanomedicine Nanotechnology Biology and Medicine. 12(8). 2373–2381. 28 indexed citations

19.

Jain, Akshay & Kun Cheng. (2016). The principles and applications of avidin-based nanoparticles in drug delivery and diagnosis. Journal of Controlled Release. 245. 27–40. 212 indexed citations

20.

Jain, Akshay, Ashutosh Barve, Zhen Zhao, Wei Jin, & Kun Cheng. (2016). Comparison of Avidin, Neutravidin, and Streptavidin as Nanocarriers for Efficient siRNA Delivery. Molecular Pharmaceutics. 14(5). 1517–1527. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact